Genetic Technologies Limited advised that Mr. Tony Di Pietro has provided his notice of resignation as Chief Financial Officer (CFO) of the Company. The Company has commenced a search for a new CFO with requisite dual ASX and Nasdaq listed company expertise. Mr. Di Pietro will remain in the role of CFO until a replacement commences with GTG or the end of March 2024, whichever date is the earliest.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | -7.69% | 0.00% | -11.11% |
1st Jan change | Capi. | |
---|---|---|
-11.11% | 10.48M | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.65% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.23% | 12.42B | |
+6.43% | 12.77B |
- Stock Market
- Equities
- GTG Stock
- News Genetic Technologies Limited
- Genetic Technologies Limited Announces Resignation of Tony Di Pietro as Chief Financial Officer